Zhen Lu – InmunoES

Calcium sulfide nanoparticles as sustained H2S donors with neuroprotective potential in ischemic stroke

17 de April de 2026 by Zhen Lu

IntroductionAcute ischemic stroke remains a major cause of death and disability, underscoring the need for safe and effective neuroprotective strategies. Hydrogen sulfide (H₂S) exhibits dose-dependent neuroprotective effects but its therapeutic applica…

Thromboembolic adverse events associated with TPO-RA in ITP treatment: a pharmacovigilance analysis of the FDA Adverse Event Reporting System

13 de February de 2026 by Zhen Lu

BackgroundThrombopoietin receptor agonists (TPO-RA) are widely used for immune thrombocytopenia (ITP), but their post-marketing thromboembolic safety profiles and onset patterns remain incompletely characterized.MethodsFAERS reports from January 2009 t…